Biomarkers for respiratory diseases: Present applications and future discoveries

Author:

Liu Xiaojing1,Cui Bo2,Wang Qian3,Ma Yuan2,Li Li4,Chen Zhihong2ORCID

Affiliation:

1. Department of Respiratory and Critical Care Medicine The Affiliated Hospital of Qingdao University Qingdao China

2. Department of Respiratory and Critical Care Medicine of Zhongshan Hospital Shanghai Institute of Respiratory Disease Fudan University Shanghai China

3. Department of Respiratory and Critical Care Medicine Shanghai Jing'an District Zhabei Central Hospital Shanghai China

4. Division of Environmental and Occupational Health Sciences National Jewish Health Denver Colorado USA

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Wiley

Reference117 articles.

1. BEST (Biomarkers EndpointS and other Tools) Resource.FDA‐NIH Biomarker Working Group. Food and Drug Administration (US); National Institutes of Health (US);2016.www.ncbi.nlm.nih.gov/books/NBK326791/

2. The role of environmental exposure to non‐cigarette smoke in lung disease

3. Eosinophils in COPD: just another biomarker?

4. The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review

5. Recent developments and highlights in biomarkers in allergic diseases and asthma

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3